Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synpeptide, formally operating as Nanjing Jiepeptide Biotechnology, is a China-based peptide synthesis and life science services company focused on custom peptides, modified peptides, active peptides, and related research products. The company serves research institutes, biotech companies, and pharmaceutical customers with peptide design, synthesis, purification, quality control, and scale-up services rather than advancing a disclosed proprietary therapeutic pipeline. Public descriptions indicate capabilities spanning long peptides, complex peptide modifications, and supply from research scale to larger-scale production. The business appears positioned primarily as a commercial peptide reagent and service provider, with additional antibody-related service offerings mentioned in some profiles. Overall, it is best characterized as a peptide-focused CRO/research supplier in the broader biotech tools and services ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synpeptide.